Stocks and Investing Stocks and Investing
Wed, November 16, 2016

CENX, AIXG, GBDC, MSCI, SCMP, RPG Are Seasonally Ripe To Go Up In the Next Five Weeks


Published on 2016-11-16 01:46:01 - WOPRAI
  Print publication without navigation


November 16, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Century Aluminum Company (NASDAQ:CENX), Aixtron Aktiengesellschaft (NASDAQ:AIXG), Golub Capital BDC Inc. (NASDAQ:GBDC), MSCI Inc. (NYSE:MSCI), Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP), Rydex S&P 500 Pure Growth ETF (NYSE:RPG) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  CENX    Century Aluminum Company         26.48%           85.00% (17 of 20)    Thursday, December 29th 2016
  AIXG    Aixtron Aktiengesellschaft       3.77%            81.82% (9 of 11)     Wednesday, November 30th 2016
  GBDC    Golub Capital BDC Inc.           3.98%            100.00% (6 of 6)     Thursday, December 22nd 2016
  MSCI    MSCI Inc.                        5.99%            100.00% (9 of 9)     Wednesday, November 30th 2016
  SCMP    Sucampo Pharmaceuticals Inc.     18.75%           88.89% (8 of 9)      Thursday, December 29th 2016
  RPG     Rydex S&P 500 Pure Growth ETF    2.52%            100.00% (10 of 10)   Thursday, December 22nd 2016
Century Aluminum Company (NASDAQ:CENX) - Century Aluminum Company, together with its subsidiaries, produces primary aluminum in the United States and Iceland. It produces standard grade and value-added primary aluminum products; and carbon products, such as anodes and cathodes. The company was founded in 1995 and is headquartered in Chicago, Illinois..

Aixtron Aktiengesellschaft (NASDAQ:AIXG) - AIXTRON SE, together with its subsidiaries, provides deposition equipment to the semiconductor industry worldwide. The company develops, produces, and installs deposition equipment for the deposition of semiconductor and other complex materials; provides process engineering, consulting, training, ongoing customer support, and after-sales services; and offers peripheral equipment and services. Its technology solutions are used to build components for electronic and opto-electronic applications that are used in displays, signaling, lighting, fiber optic communication systems, wireless and mobile telephony applications, optical and electronic storage devices, computing, and other applications. The company markets and sells its products through its direct sales organization, dealers, and sales representatives. AIXTRON SE was founded in 1983 and is headquartered in Herzogenrath, Germany..

Golub Capital BDC Inc. (NASDAQ:GBDC) - Golub Capital BDC, Inc. is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. The company seeks to invest in the United States. It primarily invests in senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants..

MSCI Inc. (NYSE:MSCI) - MSCI Inc., together with its subsidiaries, provides content, applications, and services to support the needs of institutional investors in their investment processes worldwide. The company operates through four segments: Index, Analytics, ESG, and Real Estate. The Index segment provides investment decision support tools, including equity indexes and equity index benchmarks. These products are used in various areas of the investment process, including portfolio construction and rebalancing, asset allocation, performance benchmarking and attribution, regulatory and client reporting, and index-linked investment product creation. The Analytics segment offers products and services used for portfolio construction, risk management, and reporting. The products enable institutional investors to monitor, analyze, and report on the risk and return of investments across various asset classes based on proprietary, integrated fundamental multi-factor risk models, value-at-risk methodologies, performance attribution frameworks, and asset valuation models. This segment also provides products that help investors value, model, and hedge physical assets and derivatives across market segments, including energy and commodity assets. The ESG segment offers products to institutional investors for assessing risks and opportunities arising from environmental, social, and governance issues. ESG tools are used to evaluate both individual securities and investment portfolios. The Real Estate segment provides real estate performance analysis for funds, investors, managers, lenders, and occupiers. This segment also offers index products, and services that include research, reporting, and benchmarking. The company serves asset owners, asset management firms, private wealth managers, and financial intermediaries. MSCI Inc. was founded in 1998 and is headquartered in New York, New York..

Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP) - Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research and development of proprietary drugs for the treatment of gastrointestinal, ophthalmic, autoimmune, and oncology-based inflammatory disorders in the United States, Japan, Switzerland, and internationally. The company s marketed product includes AMITIZA, a ClC-2 chloride channel activator for the treatment of chronic idiopathic constipation in adults; irritable bowel syndrome with constipation in adult women; opioid-induced constipation in patients with chronic non-cancer pain; chronic constipation; and pediatric functional constipation. Its product candidates, which are in clinical development stage comprise Cobiprostone that is in Phase IIa trials for the treatment of oral mucositis, non-erosive reflux, and symptomatic gastroesophageal reflux diseases; RTU-1096, which has completed Phase I trial for treating inflammation/immune-related disorders; and RTU-009 that is in development stage for inflammation/immune-related disorders, as well as CPP-1X/sulindac combination product, which is in phase III clinical trial for the treatment of familial adenomatous polyposis. Sucampo Pharmaceuticals, Inc. was founded in 1996 is headquartered in Rockville, Maryland. Sucampo Pharmaceuticals, Inc. is a subsidiary of S&R Technology Holdings, LLC..

Rydex S&P 500 Pure Growth ETF (NYSE:RPG) - RYDEX S&P 500 P/GWTH.

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net


Contributing Sources